UB Paderborn / Katalog / Suche / in CDI

I10 PGS/PGD evaluation of 7059 embryos from 872 in vitro fertilization (IVF) cycles using 23-chromosome single nucleotide polymorphism (SNP) or 23-chromosome comparative genomic hybridization (aCGH) microarrays

Reproductive biomedicine online, 2013-05, Vol.26, p.S4-S4

Kearns, W.G

2013

Volltextzugriff (PDF)

In vitro fertilization (IVF) with 23-chromosome pair preimplantation genetic screening (PGS) from trophectoderm biopsy is more cost effective to achieve a live birth compared to IVF alone

Fertility and sterility, 2014-09, Vol.102 (3), p.e176-e176

2014

Volltextzugriff (PDF)

Ploidy outcomes for day5 and 6 blastocysts analyzed by next generation sequencing for preimplantation genetic screening

Fertility and sterility, 2016-09, Vol.106 (3), p.e162-e162

2016

Volltextzugriff (PDF)

The incidence of deletions and duplications in preimplantation embryos as determined by enhanced next generation sequencing

Fertility and sterility, 2016-09, Vol.106 (3), p.e154-e155

2016

Volltextzugriff (PDF)

The association between mitochondrial DNA content and implantation potential during IVF and preimplantation genetic screening cycles

Fertility and sterility, 2016-09, Vol.106 (3), p.e155-e155

2016

Volltextzugriff (PDF)

In vitro fertilization (IVF) with 23-chromosome pair preimplantation genetic screening (PGS) is cost effective to achieve a live birth compared to IVF alone for recurrent pregnancy loss (RPL)

Fertility and sterility, 2013-09, Vol.100 (3), p.S99-S100

2013

Volltextzugriff (PDF)

Preimplantation genetic testing with array CGH and the transfer of euploid embryos does not decrease the rate of biochemical pregnancy after IVF

Fertility and sterility, 2014-09, Vol.102 (3), p.e231-e232

2014

Volltextzugriff (PDF)

ESHRE PGD Consortium data collection V: Cycles from January to December 2002 with pregnancy follow-up to October 2003

Human reproduction (Oxford), 2006-01, Vol.21 (1), p.3-21

2006

Volltextzugriff (PDF)

Ovarian reserve and the availability of at least one euploid embryo after preimplantation genetic screening

Fertility and sterility, 2014-09, Vol.102 (3), p.e152-e152

2014

Volltextzugriff (PDF)

The use of next-generation sequencing (NGS) for preimplantation genetic screening (PGS) and diagnosis (PGD)

Fertility and sterility, 2014-09, Vol.102 (3), p.e184-e185

2014

Volltextzugriff (PDF)

Comparative Genomic Hybridization Microarray (aCGH) Analysis of DNA Isolated from the Blastocoel Fluid from 26 Blastocysts

Fertility and sterility, 2014-02, Vol.101 (2), p.e4-e4

2014

Volltextzugriff (PDF)

Preimplantation genetic screening (PGS) on day-5 blastocysts with a day-6 embryo transfer results in a clinical pregnancy rate of 71

Fertility and sterility, 2013-09, Vol.100 (3), p.S198-S198

2013

Volltextzugriff (PDF)

The first report of a viable, 31 week gestation pregnancy following the transfer of a genetically normalized blastocyst; embryo normalization can occur during differentiation to the blastocyst stage

Fertility and sterility, 2013-09, Vol.100 (3), p.S464-S465

2013

Volltextzugriff (PDF)

Genetic normalization of differentiating aneuploid cleavage stage embryos

Fertility and sterility, 2013-09, Vol.100 (3), p.S69-S69

2013

Volltextzugriff (PDF)

The incidence of aneuploidy in differentiated blastocysts from patients with no prior first trimester spontaneous miscarriages or failed in vitro fertilization cycles

Fertility and sterility, 2013-09, Vol.100 (3), p.S203-S204

2013

Volltextzugriff (PDF)

Two different microarray technologies for preimplantation genetic diagnosis (PGD) and screening (PGS), due to reciprocal translocation imbalances, demonstrate equivalent clinical pregnancy rates

Fertility and sterility, 2013-09, Vol.100 (3), p.S36-S36

2013

Volltextzugriff (PDF)

Ovarian granulosa cells are a viable source of iPSCs with the capacity for epigenetically-biased differentiation into steroidogenic tissue of the ovary

Fertility and sterility, 2013-09, Vol.100 (3), p.S454-S454

2013

Volltextzugriff (PDF)

Blastocoel fluid (BF) harbors embryonic DNA that may result from the marginalization of aneuploid cells during embryogenesis

Fertility and sterility, 2014-09, Vol.102 (3), p.e205-e205

2014

Volltextzugriff (PDF)

All 23 chromosome pairs demonstrate a risk of aneuploidy when performing preimplantation genetic screening (PGS) on differentiated blastocysts

Fertility and sterility, 2014-09, Vol.102 (3), p.e174-e175

2014

Volltextzugriff (PDF)

The potential use of blastocoel fluid (BF) from expanded blastocysts as a less invasive form of embryo biopsy for preimplantation genetic testing

Fertility and sterility, 2014-09, Vol.102 (3), p.e183-e184

2014

Volltextzugriff (PDF)

23-chromosome single nucleotide polymorphism (SNP) microarray preimplantation genetic screening (PGS) for recurrent pregnancy loss (RPL) in 687 in vitro fertilization (IVF) cycles and 5871 embryos

Fertility and sterility, 2012-09, Vol.98 (3), p.S54-S54

2012

Volltextzugriff (PDF)

The majority of women undergoing preimplantation genetic screeining (PGS) using 23 chromosome single nucleotide polymorphism (SNP) microarrays will have euploid embryos available for uterine transfer

Fertility and sterility, 2012-09, Vol.98 (3), p.S141-S141

2012

Volltextzugriff (PDF)

Aneuploid embryos as determined by 23 single nucleotide polymorphism (SNP) microarray preimplantation genetic screening (PGS) possess the potential to genetically normalize during early development

Fertility and sterility, 2012-09, Vol.98 (3), p.S108-S108

2012

Volltextzugriff (PDF)

Detection of aneuploidy for chromosomes 4, 6, 7, 8, 9, 10, 11, 12, 13, 17, 18, 21, X and Y by fluorescence in-situ hybridization in spermatozoa from nine patients with oligoasthenoteratozoospermia undergoing intracytoplasmic sperm injection

Human reproduction (Oxford), 1999-05, Vol.14 (5), p.1266-1273

1999

Volltextzugriff (PDF)

The Incidence of Aneuploidy Significantly Increases After the Age of 40 in Women With a History of Recurrent Pregnancy Loss

Fertility and sterility, 2012-03, Vol.97 (3), p.S24-S25

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

I10 PGS/PGD evaluation of 7059 embryos from 872 in vitro fertilization (IVF) cycles using 23-chromosome single nucleotide polymorphism (SNP) or 23-chromosome comparative genomic hybridization (aCGH) microarrays

In vitro fertilization (IVF) with 23-chromosome pair preimplantation genetic screening (PGS) from trophectoderm biopsy is more cost effective to achieve a live birth compared to IVF alone

Ploidy outcomes for day5 and 6 blastocysts analyzed by next generation sequencing for preimplantation genetic screening

The incidence of deletions and duplications in preimplantation embryos as determined by enhanced next generation sequencing

The association between mitochondrial DNA content and implantation potential during IVF and preimplantation genetic screening cycles

In vitro fertilization (IVF) with 23-chromosome pair preimplantation genetic screening (PGS) is cost effective to achieve a live birth compared to IVF alone for recurrent pregnancy loss (RPL)

Preimplantation genetic testing with array CGH and the transfer of euploid embryos does not decrease the rate of biochemical pregnancy after IVF

ESHRE PGD Consortium data collection V: Cycles from January to December 2002 with pregnancy follow-up to October 2003

Ovarian reserve and the availability of at least one euploid embryo after preimplantation genetic screening

The use of next-generation sequencing (NGS) for preimplantation genetic screening (PGS) and diagnosis (PGD)

Comparative Genomic Hybridization Microarray (aCGH) Analysis of DNA Isolated from the Blastocoel Fluid from 26 Blastocysts

Preimplantation genetic screening (PGS) on day-5 blastocysts with a day-6 embryo transfer results in a clinical pregnancy rate of 71

The first report of a viable, 31 week gestation pregnancy following the transfer of a genetically normalized blastocyst; embryo normalization can occur during differentiation to the blastocyst stage

Genetic normalization of differentiating aneuploid cleavage stage embryos

The incidence of aneuploidy in differentiated blastocysts from patients with no prior first trimester spontaneous miscarriages or failed in vitro fertilization cycles

Two different microarray technologies for preimplantation genetic diagnosis (PGD) and screening (PGS), due to reciprocal translocation imbalances, demonstrate equivalent clinical pregnancy rates

Ovarian granulosa cells are a viable source of iPSCs with the capacity for epigenetically-biased differentiation into steroidogenic tissue of the ovary

Blastocoel fluid (BF) harbors embryonic DNA that may result from the marginalization of aneuploid cells during embryogenesis

All 23 chromosome pairs demonstrate a risk of aneuploidy when performing preimplantation genetic screening (PGS) on differentiated blastocysts

The potential use of blastocoel fluid (BF) from expanded blastocysts as a less invasive form of embryo biopsy for preimplantation genetic testing

23-chromosome single nucleotide polymorphism (SNP) microarray preimplantation genetic screening (PGS) for recurrent pregnancy loss (RPL) in 687 in vitro fertilization (IVF) cycles and 5871 embryos

The majority of women undergoing preimplantation genetic screeining (PGS) using 23 chromosome single nucleotide polymorphism (SNP) microarrays will have euploid embryos available for uterine transfer

Aneuploid embryos as determined by 23 single nucleotide polymorphism (SNP) microarray preimplantation genetic screening (PGS) possess the potential to genetically normalize during early development

Detection of aneuploidy for chromosomes 4, 6, 7, 8, 9, 10, 11, 12, 13, 17, 18, 21, X and Y by fluorescence in-situ hybridization in spermatozoa from nine patients with oligoasthenoteratozoospermia undergoing intracytoplasmic sperm injection

The Incidence of Aneuploidy Significantly Increases After the Age of 40 in Women With a History of Recurrent Pregnancy Loss

Suchergebnisse filtern